Protocol Ledger

NCT07304271 · Phase III · RECRUITING

Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

Interventional Phase III clinical trial protocol NCT07304271 sponsored by Magnus Nilsson in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-05 Enrollment: 262 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07304271
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)262 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07304271
Protocol FieldVerified Registry Value
NCT IdentifierNCT07304271
Consolidated Lead SponsorMagnus Nilsson
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment262 participants (ESTIMATED)
Registered Start Date2025-11-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07304271
Hospital Research SiteLocationSite Profile
Sahlgrenska University hospitalGothenburg, SwedenOpen Hospital Dossier ->
Karolinska University HospitalStockholm, SwedenOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI